Bone metastases less predictive in the setting of cytoreductive nephrectomy.
Men with metastatic castration-resistant prostate cancer with predominantly bone metastases who receive more than 4 dose of radium-223 have significantly improved overall survival than those who receive 4 or fewer doses, a study found.
Nadofaragene firadenovec, a novel gene-mediated therapy, achieved a 53.4% complete response rate in patients with high-grade carcinoma in situ unresponsive to bacillus Calmette-Guérin, phase 3 trial results show.
A new analysis of men in the CARD study showed that cabazitaxel improved pain response and decreased the likelihood of pain progression compared with either abiraterone or enzalutamide.
Despite the introduction in recent year of promising novel agents, men with newly diagnosed metastatic prostate cancer have experienced only a slight decline in death risk.
Investigators found that men treated with 5-alpha-reductase inhibitors are not more likely to die from prostate cancer or any other cause.
Despite having a high awareness of music therapy, many clinicians do not understand how it works or how to refer patients.
Mock emergency drills conducted at an ambulatory cancer center focused on scenarios dealing with respiratory distress, stroke, and use of an evacuation chair to ensure staff had experience reacting to these emergencies.
No increase in cancer-specific mortality seen in men with prostate cancer who receive organ transplants.
Corresponding nationwide decrease of 80,000 registered nurses seen during same period.
Comprehensive geriatric assessment was shown to effectively identify vulnerability to AEs in patients with HNC across all ages.
Among overweight, obese patients, cancer risk 12 percent greater compared with general population.
And mortality could be reduced by about one-third by 2030 and almost completely by 2120.
Better renal function preservation is associated with decreased cancer-specific death risk among patients who have an estimated glomerular filtration rate (eGFR) below 85 mL/min/1.73 m2 after surgery for organ-confined renal cell carcinoma, a study found.
Although all recommendations were endorsed, an expert panel also added discussion points regarding treatments for reducing skeletal-related events in and improving survival in patients with bone metastases.